Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 2
1988 1
1992 2
1994 5
1996 3
1997 1
1998 1
1999 3
2000 3
2001 2
2002 1
2003 3
2004 3
2005 1
2006 6
2007 2
2008 4
2009 6
2010 12
2011 10
2012 14
2013 11
2014 11
2015 8
2016 10
2017 7
2018 12
2019 6
2020 4
2021 7
2022 8
2023 5
2024 10
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Narayana S, Krishnan T, Ramakrishnan S, Austin A, Lietman T, Rose-Nussbaumer J. Narayana S, et al. Among authors: krishnan t. Ophthalmology. 2019 Nov;126(11):e86-e87. doi: 10.1016/j.ophtha.2019.07.003. Ophthalmology. 2019. PMID: 31635709 No abstract available.
Curative therapy for rectal cancer.
Alawawdeh A, Krishnan T, Roy A, Karapetis C, Joshi R, Singhal N, Price T. Alawawdeh A, et al. Among authors: krishnan t. Expert Rev Anticancer Ther. 2021 Feb;21(2):193-203. doi: 10.1080/14737140.2021.1845145. Epub 2021 Jan 8. Expert Rev Anticancer Ther. 2021. PMID: 33161803 Review.
Targeting Mutated KRAS Genes to Treat Solid Tumours.
Krishnan T, Roberts-Thomson R, Broadbridge V, Price T. Krishnan T, et al. Mol Diagn Ther. 2022 Jan;26(1):39-49. doi: 10.1007/s40291-021-00564-0. Epub 2021 Dec 16. Mol Diagn Ther. 2022. PMID: 34914038 Review.
The current landscape of neoadjuvant therapy for resectable colon cancer.
Chan M, Krishnan T, Townsend A, Karapetis C, Roy A, Foo T, Tebbutt N, Dhillon T, Price T. Chan M, et al. Among authors: krishnan t. Expert Rev Anticancer Ther. 2025 Aug;25(8):901-913. doi: 10.1080/14737140.2025.2517881. Epub 2025 Jun 10. Expert Rev Anticancer Ther. 2025. PMID: 40478728 Review.
Recent advancements in melanoma management.
Krishnan T, Menzies AM, Roberts-Thomson R. Krishnan T, et al. Intern Med J. 2021 Mar;51(3):327-333. doi: 10.1111/imj.15228. Intern Med J. 2021. PMID: 33738950 Review.
Applying adjuvant therapy for melanoma into clinical practice.
Krishnan T, Menzies AM, Roberts-Thomson R. Krishnan T, et al. Expert Rev Anticancer Ther. 2021 Feb;21(2):129-133. doi: 10.1080/14737140.2021.1841641. Epub 2020 Nov 1. Expert Rev Anticancer Ther. 2021. PMID: 33094675 No abstract available.
Real-world outcomes of lenvatinib therapy for advanced neuroendocrine neoplasms.
Solar Vasconcelos JP, Nunez Rodriguez JE, Zaidi A, Krishnan T, Jafari H, Gill S, Tan A, Le D, Chan T, Yu S, McGhie JP, Lim H, Singh S, Loree JM. Solar Vasconcelos JP, et al. Among authors: krishnan t. Endocr Relat Cancer. 2025 Feb 24;32(4):e240292. doi: 10.1530/ERC-24-0292. Print 2025 Apr 1. Endocr Relat Cancer. 2025. PMID: 39928294
167 results